Interest from investors, developers and lenders into the life science real estate sector has continued to soar. It is not a sector that disappears as the global impact of Covid-19 recedes, as the structural shifts required to ensure that human health issues are addressed will continue to call for scientific discovery, which in turn requires real estate.
This event will feature an exclusive preview of the next edition of the
Savills Life Sciences: Trends & Outlook research report, which will focus on longevity and resilience in the science real estate sector.
We will begin with an insightful presentation from Steve Lang, Head of Life Science Research at Savills and Kat Martindale, Head of ESG Research at Savills summarising the takeaways of this report.
This will be followed by an interactive Q&A session, moderated by Sarah Thorley, Strategic Advisory EMEA lead at Savills, with a panel of experts representing the perspective of developers, investors and occupiers across the sector.
There will be an opportunity for networking over a light breakfast before the presentation and panel, and over coffee after. Attendees will be able to ask questions during the session and it is open to those who know a lot about life science and those who know very little!
Why is life science real estate so relevant?
Whilst the volume of capital raised in the life science sector, including corporate M&A or venture capital, fell in 2022, venture capitalists are sat on record levels of "dry powder" following tens of billions being raised in the past couple of years. In parallel, annual R&D spend of the top ten pharma companies rose 13% on average last year. This investment into the sector will continue to stimulate demand for suitable real estate space, including labs, offices and manufacturing facilities. However, these specialist uses are often energy intensive and challenging to manage. Indeed, laboratories consume up to ten times more energy per square metre than standard commercial office buildings so they require careful design to ensure operational efficiency. Our event will aim to explore some of these opportunities and challenges for life science real estate investment.
Savills
Global HQ 33 Margaret Street
London
W1G 0JD